GE Vernova Inc vs OneSpan Inc — how do they compare? GE Vernova Inc trades at $1,021.8 (market cap $283.57B), while OneSpan Inc trades at $15.6 (market cap $571.66M). The key difference: GE Vernova Inc is far larger — about 496× OneSpan Inc's market cap, and OneSpan Inc pays the higher dividend (3.37%). Which is the better fit depends on your goals.
| GEV | OSPN | |
|---|---|---|
Market Cap | $283.57B | $571.66M |
Sector | Technology | Technology |
52-Week High | $1.17K | $16.32 |
52-Week Low | $547.96 | $10.15 |
Enterprise Value | $276.21B | $529.87M |
Dividend Yield | 0.19% | 3.37% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OSPN trades at $15.70, up 1.36% today, with a bullish technical signal from moving averages and strong profitability metrics including a 28.47% net income margin and 27.81% ROE. Recent earnings beats and a scheduled Q2 2026 report on August 4, 2026, highlight operational momentum, while a dividend payment in June 2026 adds shareholder return.
The stock presents a value opportunity with a P/E of 8.52, supported by analyst consensus of Buy (66.7%) and a $13.50 price target. Risks include negative net cash flow trends and competitive pressures in cybersecurity, but earnings consistency and institutional optimism suggest upside potential.
Trailing returns across standard periods
Latest headlines on both assets
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →